beacon-intelligence.com Open in urlscan Pro
20.50.64.6  Public Scan

Form analysis
3 forms found in the DOM

GET /

<form class="search-form" method="get" action="/">
  <input type="text" name="s" placeholder="Search...">
</form>

GET https://beacon-intelligence.com/

<form role="search" method="get" class="wpr-search-form" action="https://beacon-intelligence.com/">
  <label for="search-form-645bcbed65455"></label>
  <input type="search" class="wpr-search-field" placeholder="Search..." value="" name="s" title="Search for:">
  <button type="submit" class="wpr_submit">
    <i class="wpr-icon-search"></i>
  </button>
</form>

GET https://beacon-intelligence.com/

<form role="search" method="get" class="wpr-search-form" action="https://beacon-intelligence.com/">
  <label for="search-form-645bcbed71f24"></label>
  <input type="search" class="wpr-search-field" placeholder="Search..." value="" name="s" title="Search for:">
  <button type="submit" class="wpr_submit">
    <i class="wpr-icon-search"></i>
  </button>
</form>

Text Content

 * Home
 * Solutions
   * Beacon ADC
   * Beacon Adoptive Cell
   * Beacon Bispecific
   * Beacon Cancer Vaccine
   * Beacon Checkpoint
   * Beacon Cytokine
   * Beacon DDR
   * Beacon Gene Therapy
   * Beacon Microbiome
   * Beacon Oncolytic Viruses
   * Beacon RNA
   * Beacon TPD
 * About
   * News
 * Events
 * Resources
 * Contact
 * Login




MAKE FASTER, BETTER DRUG DEVELOPMENT DECISIONS

With a growing focus on inducing immune tolerance to help treat debilitating
immune-mediated diseases, Beacon Immune Tolerance provides a comprehensive
database of all therapies within the field.

Covering all immune tolerance therapies, immunnomodulators, immunostimulants,
and immunosuppressives, this solution is the one-stop-shop to help companies
benchmark their assets against their competitors, and allows them to quickly
keep track of the latest data in the field. 

Request a demoFind out more

Home > Beacon Immune Tolerance


BEACON IMMUNE TOLERANCE

TRACK THE CLINICAL TRIAL AND DRUG DEVELOPMENT LANDSCAPE FOR IMMUNE TOLERANCE

WHAT WE COVER

Beacon Immune Tolerance covers all pharmaceutical interventions used to treat
autoimmune diseases, autoinflammatory diseases, alloimmune diseases and
allergies.

From small molecules to CAR T therapy, the module encapsulates all drugs and
therapies within the immune-mediated disease space.

HOW BEACON HELPS

Here are a few use cases that have benefitted our clients in accelerating their
immune tolerance development programs:

 * Search therapeutics in the immune-disease space across all stages of
   development so you can accurately benchmark your strategies against all
   existing immune tolerance and immunomodulatory drugs, and investigate the
   novel technologies being used by competitors
 * Drastically reduce manual research time spent looking through publications
   and conference abstracts for preclinical and clinical trial results by
   relying on our comprehensive collection of data which can be searched by a
   variety of options including delivery system, cell type, disease indications
   and much more.
 * Stay on top of emerging trends and new players in the immune tolerance field
   with real-time updates and alerts, as well as in-depth monthly reports
   curated by our analyst team.

HOW BEACON IMMUNE TOLERANCE WORKS

All Immune Tolerance pages will have unique data fields that will help speed up
the research process. These data fields include:

 * Antigen specificity
 * Mechanism of Action
 * Cell Source
 * Cell Type
 * Delivery System
 * Editing Technology
 * Target Organ/Cell
 * Formulation

Our unique Milestones filter and visualization highlights past, present, and
future drug development milestones including drug and trial readouts, asset
history, and regulatory announcements. This enhancement provides an accurate,
timely and exhaustive single-drug timeline allowing you to benchmark progress in
the immune tolerance space.

HOW WE TARGET THE DATA FOR IMMUNE TOLERANCE

We house all publicly available sources of data updated with 24 – 48 hours of
publication proactively.  Our sources cover (but are not limited to):

 * Clinical trials registries
 * Scientific journals and publications
 * Company reports and presentations
 * Press releases
 * Conference reports and abstracts
 * Government and regulatory organizations
 * Newspapers and other media
 * Patents




RELATED CONTENT

GENE THERAPY: ASGCT ANNUAL MEETING 2023 ABSTRACTS

Find out more

CANCER VACCINE INFOGRAPHIC 2023

Find out more

ADOPTIVE CELL: AACR ANNUAL MEETING 2023 ABSTRACTS

Find out more


WHAT OUR CUSTOMERS SAY


BEACON IS A GREAT DATABASE THAT PEOPLE SHOULD PAY ATTENTION TO. IT'S MUCH BETTER
THAN MANY GENERIC DATABASES THAT TRY TO CAPTURE ALL DATA ABOUT EVERYTHING.

Director
Top Biotech Company


OUR IMMUNE TOLERANCE EXPERT

THOMAS HALL IS THE LEAD RESEARCH ANALYST FOR THE IMMUNE TOLERANCE MODULE.

Sign up to his weekly newsletter with the latest insights into the immunology
landscape using data from Beacon Immune Tolerance.

Subscribe to newsletter


OTHER BEACON SOLUTIONS

ADC
Adoptive Cell
Bispecific
Cancer Vaccine
Checkpoint
Cytokine
DDR
Gene Therapy
Microbiome
RNA
TPD

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates
(SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

 

Covering all engineered and non-engineered immune cell therapies, including
CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

 

Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented
Antibodies and more

Find out more

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic
and therapeutic cancer vaccines field.

Find out more

 

Covering all Immune Checkpoint Combination Trials and Immune Checkpoint
Modulators in development across 27 different checkpoint targets

Find out more

 

Covering all cytokines and drugs that target a cytokine or its immediate
receptor belonging to the Interleukins, Interferons, Colony-stimulating factors,
Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

 

Beacon DDR steps into the field to give drug developers the precise detailed
view and broader picture of what is truly happening in the DDR field.

Find out more

 

From gene-editing technologies, novel delivery systems, and a variety of genetic
materials being used- Beacon Gene Therapy steps into the field to give drug
developers a precise and detailed view of how the gene therapy landscape looks.

Find out more

 

Covering all pharmaceutical grade microbiome-based therapeutics across all
disease indications – Beacon Microbiome provides drug developers with detailed
views of the expanding microbiome landscape.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene
Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers
all disease indications and many modalities to provide a detailed landscape of
the RNA space.

Find out more

 

Beacon TPD provides the solution you need to master the targeted protein
degradation field.

Find out more


ANY QUESTIONS? CONTACT US

TO LEARN MORE ABOUT HOW WE CAN TAILOR BEACON IMMUNE TOLERANCE TO HELP YOU, GET
IN TOUCH WITH OUR SALES TEAM

 

ALEX REYNOLDS AND LUKA VUKOJE

Account Managers

Contact the Team

ABOUT BEACON

Beacon is the essential decision-support tool for developers of complex
therapeutics. Our market-defining, proprietary ontologies and the most accurate
and comprehensive life sciences data provide our customers with unparalleled
visibility of the drug and trial landscape.

With Beacon, you can make drug development decisions with confidence. This is
why 23 of the world’s top 25 drug developers trust us.

USEFUL LINKS

 * About
 * Contact
 * Events
 * FAQS
 * Resources
 * Solutions
 * Careers

SOLUTIONS

 * Beacon Immune Tolerance
 * Beacon RNA
 * Beacon Cancer Vaccine
 * Beacon DDR
 * Beacon Gene Therapy
 * Beacon Bispecific
 * Beacon ADC

 * Beacon Microbiome
 * Beacon Cytokine
 * Beacon TPD
 * Beacon Oncolytic Viruses
 * Beacon Checkpoint
 * Beacon Adoptive Cell

LATEST CONTENT

 * Oncolytic Viruses: ASGCT Annual Meeting 2023 Abstracts
 * Adoptive Cell: ASGCT Annual Meeting 2023 Abstracts
 * Gene Therapy: ASGCT Annual Meeting 2023 Abstracts
 * 8th Microbiome Movement – Drug Development Summit
 * 5th Annual Allogeneic Cell Therapies Summit

 * Terms & Conditions
 * Site Map

© 2023 TOAST DESIGN | Reg Office: 52 Grosvenor Gardens, London, SW1W 0AU. Beacon
is a trading name of Hanson Wade
Follow us on social media

 * 
 * Home
 * Solutions
   * Beacon ADC
   * Beacon Adoptive Cell
   * Beacon Bispecific
   * Beacon Cancer Vaccine
   * Beacon Checkpoint
   * Beacon Cytokine
   * Beacon DDR
   * Beacon Gene Therapy
   * Beacon Microbiome
   * Beacon Oncolytic Viruses
   * Beacon RNA
   * Beacon TPD
 * About
   * News
 * Events
 * Resources
 * Contact
 * Login
 * 
 * 




This is the brochure-popup

This is the contact us popup